# Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder

> **NCT01871974** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 16 (actual)

## Conditions studied

- Major Depressive Disorder Patients

## Interventions

- **DRUG:** FK949E

## Key facts

- **NCT ID:** NCT01871974
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01871974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01871974, "Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01871974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*